Method of treating joint disorders using hydroxamic derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514212, 5142278, 5142352, 514253, 514323, 514326, 5142305, 514417, 5142362, 5142358, 5142355, A61K 31535, A61K 3154

Patent

active

054479290

ABSTRACT:
Hydroxamic acid derivatives of the fdrrnula ##STR1## and pharmaceutically acceptable salts thereof, which are collagenase inhibitors useful for the control or prevention of degenerative joint diseases, such as, rheumatoid arthritis and ostecarthritis or for the treatment of invasive tumours, atherosclerosis or multiple sclerosis, are described. Said compounds can be prepared either by hyclroxamidating a corresponding carboxylic acid or deprotecting a corresponding benzyloxycarbamoyl compound.

REFERENCES:
patent: 4743587 (1988-05-01), Dickens et al.
Dayer, et al. Proc. Natl. Acad. Sci. USA(1976), 73,945.
Johnson-Wint. B. Anal. Biochem. (1980) 104, 175.
Handa, et al., Chemical Abstracts, vol. 108, (1988) No. 167,973e.
Broadhurst, et al. Chemical Abstracts, vol. 118, (1993) No. 169,601n.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of treating joint disorders using hydroxamic derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating joint disorders using hydroxamic derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating joint disorders using hydroxamic derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-472900

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.